Infinium Pharmachem Ltd. (INFINIUM-SM): Infinium Pharmachem Share Price rises 9.86% to Rs 244; market cap at Rs 354.91 crore

Published: 25 August 2026 at 11:01:40 AM IST

Infinium Pharmachem Share Price rose to Rs 244 today, up 9.86% from the previous close of Rs 222.10, with market capitalisation at Rs 354.91 crore. The stock’s move also takes it to the day’s high of Rs 244 after opening at Rs 229.50 and touching a low of Rs 226.85. The supplied data confirms the price event, while a company-specific catalyst is not established in the available information. For readers tracking Infinium Pharmachem Share Price Today, the key question is how today’s price action compares with its chemicals-sector valuation, profitability and peer set. Univest is covering the stock as part of today’s Stock Market Today and Share Market Today update, with a focus on verified facts rather than speculation.

In this Infinium Pharmachem Stock News update, the rise is relevant because it comes alongside a turnover of Rs 0.63 crore and a valuation profile that sits above several industry median benchmarks. Investors following Infinium Pharmachem Share Price News can use today’s move as a fresh reference point for stock analysis, fundamental analysis and broader market update monitoring on Univest.

Infinium Pharmachem Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 244
Previous Close	Rs 222.1
Today's Move	Rs 21.9 (+9.86%)
Open	Rs 229.5
High	Rs 244
Low	Rs 226.85
Turnover	Rs 0.63 crore
Market Capitalisation	Rs 354.91 crore
Market Cap Category	Micro Cap

Infinium Pharmachem Ltd. (INFINIUM-SM) rose to Rs 244 from the previous close of Rs 222.1, a move of Rs 21.9 or 9.86%. The stock opened at Rs 229.5, reached a high of Rs 244, recorded a low of Rs 226.85.

Infinium Pharmachem Share Price Today closed the session higher at Rs 244, adding Rs 21.90 or 9.86% versus the previous close of Rs 222.10. The stock opened at Rs 229.50, traded between Rs 226.85 and Rs 244, and finished at the day’s high. Turnover for the session stood at Rs 0.63 crore. These numbers describe a clear same-day price rise without assigning a cause beyond the verified data. For readers scanning Stocks in News, the move places Infinium Pharmachem among the day’s notable gainers, though the available record does not establish a company-specific catalyst.

The price behaviour is useful for Infinium Pharmachem Share Price Update tracking because it shows the full day range, opening level and close in one session. Univest users comparing Infinium Pharmachem Share Price Live with broader market updates can see that the stock ended above its open and previous close, while the supplied facts remain limited to the observed market data.

Infinium Pharmachem Ltd. (INFINIUM-SM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 354.91 crore
P/E Ratio	28.49x
P/B Ratio	3.16x
ROE	9.32%
ROCE	13.23%
EPS	Rs 7.8
Book Value Per Share	Rs 70.25
Dividend Yield	0%

Infinium Pharmachem Ltd. (INFINIUM-SM) fundamental metrics show P/E 28.49x, P/B 3.16x, ROE 9.32%, ROCE 13.23%. These figures provide context only and are not a buy or sell signal.

Infinium Pharmachem Ltd. has a market capitalisation of Rs 354.91 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 28.49x, P/B at 3.16x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.32% and ROCE of 13.23%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 7.8, book value per share of Rs 70.25, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 24.84x, median ROE of 7.8%, median ROCE of 10.02%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Chemicals
Industry	Chemicals
Benchmark Scope	same industry
Company P/E Ratio	28.49x
Benchmark Median P/E	24.84x
Benchmark Average P/E	46.19x
Benchmark P/E Range	4.39x to 743.02x
Company P/B Ratio	3.16x
Benchmark Median P/B	1.89x
Company ROE	9.32%
Benchmark Median ROE	7.8%
Company ROCE	13.23%
Benchmark Median ROCE	10.02%
Company Market Capitalisation	Rs 354.91 crore
Benchmark Median Market Cap	Rs 501.33 crore

Infinium Pharmachem Ltd. (INFINIUM-SM) is classified under sector: Chemicals and industry: Chemicals.

Infinium Pharmachem Ltd. (INFINIUM-SM) has a P/E ratio of 28.49x, which is above the benchmark median of 24.84x, a difference of +14.69%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Infinium Pharmachem Ltd. (INFINIUM-SM) has a ROE of 9.32%, which is above the benchmark median of 7.8%, a difference of +19.49%. Infinium Pharmachem Ltd. (INFINIUM-SM) has a ROCE of 13.23%, which is above the benchmark median of 10.02%, a difference of +32.04%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Solar Industries India Ltd.	SOLARINDS	1,80,142.17	89.16	25.6	32.49	38.16
Pidilite Industries Ltd.	PIDILITIND	1,67,461.57	63.71	14.6	24.29	32.38
SRF Ltd.	SRF	76,372.37	35.39	5.18	13.8	14.21
Gujarat Fluorochemicals Ltd.	FLUOROCHEM	50,805.08	82.53	6.32	8.31	10.02
Navin Fluorine International Ltd.	NAVINFLUOR	42,046.27	53.25	10.01	20.24	21.39

Infinium Pharmachem Ltd. (INFINIUM-SM) has a P/E ratio of 28.49x compared with the displayed peer median of 63.71x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.32% compares with a peer median of 20.24% across the companies shown in the table. ROCE stood at 13.23% versus the displayed peer median of 21.39%, providing a capital-efficiency comparison. Infinium Pharmachem Ltd. (INFINIUM-SM) has a market capitalisation of Rs 354.91 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Infinium Pharmachem

• Infinium Pharmachem Share Price rose 9.86% today to Rs 244, with the move ending at the day’s high of Rs 244.
• The stock moved from a previous close of Rs 222.10 to an open of Rs 229.50, and the day range was Rs 226.85 to Rs 244.
• Market capitalisation stands at Rs 354.91 crore, which gives the Infinium Pharmachem Share Price event a defined size context.
• P/E is 28.49, P/B is 3.16, EPS is Rs 7.80 and book value is Rs 70.25, which frames the valuation discussion.
• ROE of 9.32% and ROCE of 13.23% are both above the industry medians in the same-industry benchmark set used by Univest.

About Infinium Pharmachem

Infinium Pharmachem Ltd. is part of the Chemicals sector and Chemicals industry. Based on the supplied data, the company is evaluated here through its market cap, valuation ratios and profitability metrics rather than an extended business description. The key operating picture available in this article is financial: a market cap of Rs 354.91 crore, a P/E ratio of 28.49, a P/B ratio of 3.16, ROE of 9.32%, ROCE of 13.23%, EPS of Rs 7.80 and book value of Rs 70.25. Dividend yield is 0. For readers using Univest, this makes the Infinium Pharmachem Share Price move easier to place within a broader company overview, financial analysis and sector analysis framework. The day’s rise is therefore best read alongside the company’s published ratios and the chemicals industry benchmark rather than in isolation.

Track Infinium Pharmachem Share Price on Univest

Use Infinium Pharmachem Ltd. (INFINIUM-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Infinium Pharmachem Share Price on Univest for live share price updates, financial ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers review Infinium Pharmachem Stock News, Infinium Pharmachem News Today, Infinium Pharmachem Share News and Infinium Pharmachem Stock Performance in one place. For market update tracking, the same page can be used to follow valuation ratios, fundamentals and price action as new data arrives.

Frequently Asked Questions

Why did Infinium Pharmachem Share Price rise today?

Ans. Infinium Pharmachem Share Price rose 9.86% to Rs 244 today, but the supplied data does not establish a company-specific catalyst. The event is confirmed by the price change, opening level, high, low and turnover figures.

What is Infinium Pharmachem Share Price today?

Ans. Infinium Pharmachem Share Price today is Rs 244. The stock gained Rs 21.90 from the previous close of Rs 222.10 and finished at the day’s high, according to the supplied market data.

What is the market cap of Infinium Pharmachem?

Ans. Infinium Pharmachem’s market cap is Rs 354.91 crore. That places the company below the same-industry benchmark median market cap of Rs 501.33 crore, based on the supplied chemicals-sector comparison set.

How does Infinium Pharmachem look on valuation?

Ans. Infinium Pharmachem trades at a P/E ratio of 28.49 and a P/B ratio of 3.16. Both sit above the same-industry medians of 24.84 and 1.89, respectively, in the supplied benchmark set.

What do Infinium Pharmachem ROE and ROCE show?

Ans. ROE is 9.32% and ROCE is 13.23%. Both are above the benchmark medians of 7.80% and 10.02%, which provides useful context for Infinium Pharmachem Share Price analysis and fundamental review.

What are Infinium Pharmachem EPS and book value?

Ans. EPS is Rs 7.80 and book value is Rs 70.25. EPS represents earnings per share, while book value shows accounting net worth per share, both useful for reading the Infinium Pharmachem Share Price move.

Does Infinium Pharmachem pay a dividend?

Ans. The supplied dividend yield is 0, so there is no current dividend yield to factor into the stock’s profile. Investors tracking Infinium Pharmachem Share Price can still review earnings, valuation and sector comparison.

How does Infinium Pharmachem compare with chemicals peers?

Ans. Infinium Pharmachem is much smaller than peers such as Solar Industries, Pidilite and SRF by market cap. Its P/E is lower than several peers, while ROE and ROCE sit in the mid-range of the comparison set.